Journal article
Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse
Abstract
BACKGROUND: Patients with chronic migraine and medication overuse are significant consumers of health care resources.
OBJECTIVE: To determine whether botulinum toxin type A prophylaxis reduces the cost of acute migraine medications in patients with chronic migraine and triptan overuse.
Authors
Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
Journal
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 37, No. 5, pp. 588–594
Publisher
Cambridge University Press (CUP)
Publication Date
September 2010
DOI
10.1017/s031716710001074x
ISSN
0317-1671